FDA meeting will explore gender, CBD

Share this:

The U.S. Food & Drug Administration will host a public meeting this Thursday, Nov. 19 to discuss whether CBD and other cannabinoids have different effects on men and women. FDA said the meeting should interest researchers, educators, clinicians and patients. Other presentations will address patient and healthcare provider perspectives on CBD and other cannabinoids, use of CBD and other cannabinoids in pregnancy, and government agency perspectives on CBD research.

Get Hemp Industry Updates

* indicates required

Newsletter Signup

Subscribe to our FREE email newsletter & get the latest hemp industry news directly in your inbox.

* indicates required
Scroll to Top